Literature DB >> 30770568

Thyroid hormone receptor function in maturing ovine cardiomyocytes.

Natasha N Chattergoon1,2, Samantha Louey1,2, Thomas Scanlan3, Isa Lindgren1,2, George D Giraud1,3,2,4, Kent L Thornburg1,3,2.   

Abstract

KEY POINTS: Plasma thyroid hormone (tri-iodo-l-thyronine; T3 ) concentrations rise near the end of gestation and is known to inhibit proliferation and stimulate maturation of cardiomyocytes before birth. Thyroid hormone receptors are required for the action of thyroid hormone in fetal cardiomyocytes. Loss of thyroid hormone receptor (TR)α1 abolishes T3 signalling via extracellular signal-related kinase and Akt in fetal cardiomyocytes. The expression of TRα1 and TRβ1 in ovine fetal myocardium increases with age, although TRα1 levels always remain higher than those of TRβ1. Near term fetal cardiac myocytes are more sensitive than younger myocytes to thyroid receptor blockade by antagonist, NH3, and to the effects of TRα1/α2 short interfering RNA. Although T3 is known to abrogate ovine cardiomyocyte proliferation stimulated by insulin-like growth factor 1, this effect is mediated via the genomic action of thyroid hormone receptors, with little evidence for non-genomic mechanisms. ABSTRACT: We have previously shown that the late-term rise in tri-iodo-l-thyronine (T3 ) in fetal sheep leads to the inhibition of proliferation and promotion of maturation in cardiomyocytes. The present study was designed to determine whether these T3 -induced changes are mediated via thyroid hormone receptors (TRs) or by non-genomic mechanisms. Fetal cardiomyocytes were isolated from 102 ± 3 and 135 ± 1 days of gestational age (dGA) sheep (n = 7 per age; term ∼145 dGA). Cells were treated with T3 (1.5 nm), insulin-like growth factor (IGF)-1 (1 μg mL-1 ) or a combination in the presence of TR antagonist NH3 (100 nm) or following short interfering RNA (siRNA) knockdown of TRα1/α2. Proliferation was quantified by 5-bromo-2'-deoxyuridine (BrdU) uptake (10 μm). Western blots measured protein levels of extracellular signal-related kinase (ERK), Akt, TRα1/β1 and p21. Age specific levels of TRα1/β1 were measured in normal hearts from fetuses [95 dGA (n = 8), 135 dGA (n = 7)], neonates (n = 8) and adult ewes (n = 7). TRα1 protein levels were consistently >50% more than TRβ1 at each gestational age (P < 0.05). T3 reduced IGF-1 stimulated proliferation by ∼50% in 100 dGA and by ∼75% in 135 dGA cardiomyocytes (P < 0.05). NH3 blocked the T3  + IGF-1 reduction of BrdU uptake without altering the phosphorylation of ERK or Akt at both ages. NH3 did not suppress T3 -induced p21 expression in 100 dGA cardiomyocytes in 135 dGA cardiomyocytes, NH3 alone reduced BrdU uptake (-28%, P < 0.05), as well as T3 -induced p21 (-75%, P < 0.05). In both ages, siRNA knockdown of TRα1/α2 blocked the T3  + IGF-1 reduction of BrdU uptake and dramatically reduced ERK and Akt signalling in 135 dGA cardiomyocytes. In conclusion, TRs are required for normal proliferation and T3 signalling in fetal ovine cardiomyocytes, with the sensitivity to TR blockade being age-dependent.
© 2019 The Authors. The Journal of Physiology © 2019 The Physiological Society.

Entities:  

Keywords:  Cardiomyocyte proliferation; Fetal; NH3; Thyroid hormone

Mesh:

Substances:

Year:  2019        PMID: 30770568      PMCID: PMC6462488          DOI: 10.1113/JP276874

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  57 in total

Review 1.  Developmental patterning of the myocardium.

Authors:  D Sedmera; T Pexieder; M Vuillemin; R P Thompson; R H Anderson
Journal:  Anat Rec       Date:  2000-04-01

2.  An intrinsic timer that controls cell-cycle withdrawal in cultured cardiac myocytes.

Authors:  P B Burton; M C Raff; P Kerr; M H Yacoub; P J Barton
Journal:  Dev Biol       Date:  1999-12-15       Impact factor: 3.582

3.  Developmental expression analysis of thyroid hormone receptor isoforms reveals new insights into their essential functions in cardiac and skeletal muscles.

Authors:  P White; K A Burton; A L Fowden; M J Dauncey
Journal:  FASEB J       Date:  2001-06       Impact factor: 5.191

4.  Right ventricular systolic pressure load alters myocyte maturation in fetal sheep.

Authors:  A Barbera; G D Giraud; M D Reller; J Maylie; M J Morton; K L Thornburg
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-10       Impact factor: 3.619

Review 5.  The role of thyroid hormone receptors in the heart.

Authors:  Wolfgang H Dillmann; Bernd R Gloss
Journal:  Methods Mol Biol       Date:  2002

6.  Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment.

Authors:  Ngoc-Ha Nguyen; James W Apriletti; Suzana T Cunha Lima; Paul Webb; John D Baxter; Thomas S Scanlan
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

7.  Comparison of inhibitory effects of 3,5,3'-triiodothyronine (T3), thyroxine (T4), 3,3,',5'-triiodothyronine (rT3), and 3,3'-diiodothyronine (T2) on thyrotropin-releasing hormone-induced release of thyrotropin in the rat in vitro.

Authors:  I J Chopra; H E Carlson; D H Solomon
Journal:  Endocrinology       Date:  1978-08       Impact factor: 4.736

Review 8.  Nongenomic actions of thyroid hormone on the heart.

Authors:  Paul J Davis; Faith B Davis
Journal:  Thyroid       Date:  2002-06       Impact factor: 6.568

Review 9.  Cellular action of thyroid hormone on the heart.

Authors:  W H Dillmann
Journal:  Thyroid       Date:  2002-06       Impact factor: 6.568

10.  A thyroid hormone antagonist that inhibits thyroid hormone action in vivo.

Authors:  Wayland Lim; Ngoc-Ha Nguyen; Ha Yung Yang; Thomas S Scanlan; J David Furlow
Journal:  J Biol Chem       Date:  2002-07-02       Impact factor: 5.157

View more
  2 in total

Review 1.  Mitochondria and metabolic transitions in cardiomyocytes: lessons from development for stem cell-derived cardiomyocytes.

Authors:  Jessica C Garbern; Richard T Lee
Journal:  Stem Cell Res Ther       Date:  2021-03-12       Impact factor: 6.832

Review 2.  Thyroid hormone signaling and consequences for cardiac development.

Authors:  Natasha N Chattergoon
Journal:  J Endocrinol       Date:  2019-07-01       Impact factor: 4.286

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.